Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RPS6KB2 | Q9UBS0 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.34 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.34 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL799817 | 0.99 | RPS6KB2 (0.34) | RPS6KB2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL799957 | 0.92 | HPGD (0.36) | RPS6KB2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL799558 | 0.91 | HPGD (0.36) | RPS6KB2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL799843 | 0.85 | HDAC3 (0.36) | RPS6KB2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL799845 | 0.84 | HDAC3 (0.35) | RPS6KB2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL25701027 | 0.75 | RPS6KB2 (0.50) | RPS6KB2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL7611281 | 0.74 | HPGD (0.46) | HPGD | |
| SCHEMBL799792 | 0.73 | DPP4 (0.36) | RPS6KB2DPP4 | |
| SCHEMBL799556 | 0.72 | DPP4 (0.38) | RPS6KB2DPP4 | |
| SCHEMBL14867609 | 0.72 | DPP4 (0.51) | HDAC6HPGDDPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8663451-B2 | Linker, impedance biochip, and method of quantitatively detecting target analyte in fluid sample using the biochip | NATIONAL TAIWAN UNIVERSITY (TW) | 2014-03-04 | — | — | US | disclosed |
| US-20120067742-A1 | LINKER, IMPEDANCE BIOCHIP, AND METHOD OF QUANTITATIVELY DETECTING TARGET ANALYTE IN FLUID SAMPLE USING THE BIOCHIP | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120067742-A1 | LINKER, IMPEDANCE BIOCHIP, AND METHOD OF QUANTITATIVELY DETECTING TARGET ANALYTE IN FLUID SAMPLE USING THE BIOCHIP | EPCAM, CA13, CD44 | RPS6KB2 4851/4885HDAC3 3710/4885HDAC4 4073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.